ea0081ep726 | Pituitary and Neuroendocrinology | ECE2022
Elleuch Mouna
, Frikha Hamdi
, Fatma Loukil
, Salah Dhoha Ben
, Souissi Matiem
, Mnif Fatma
, Mnif Mouna
, Charfi Nadia
, Majdoub Nabila Rekik
, Akid Faten Haj Kacem
, Abid Mohamed
Introduction and aim: Dopamine agonists (DA) are prescribed as first-line treatment for prolactinomas and are generally effective and well tolerated. However, the degree and quickness of therapeutic response is variable among patients. The aim of this work is to study the predictive factors of biological remission in patients with prolactinoma treated with DA. Methods: A single-center, retrospective and analytical study of patients with prolactinoma foll...